132 related articles for article (PubMed ID: 11196176)
1. High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications.
Rigaud G; Missiaglia E; Moore PS; Zamboni G; Falconi M; Talamini G; Pesci A; Baron A; Lissandrini D; Rindi G; Grigolato P; Pederzoli P; Scarpa A
Cancer Res; 2001 Jan; 61(1):285-92. PubMed ID: 11196176
[TBL] [Abstract][Full Text] [Related]
2. Deletion of chromosome 1, but not mutation of MEN-1, predicts prognosis in sporadic pancreatic endocrine tumors.
Guo SS; Wu AY; Sawicki MP
World J Surg; 2002 Jul; 26(7):843-7. PubMed ID: 11960210
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity analysis in uterine cervical adenocarcinoma.
Miyai K; Furugen Y; Matsumoto T; Iwabuchi K; Hirose S; Kinoshita K; Fujii H
Gynecol Oncol; 2004 Jul; 94(1):115-20. PubMed ID: 15262128
[TBL] [Abstract][Full Text] [Related]
4. Malignancy-associated allelic losses on the X-chromosome in foregut but not in midgut endocrine tumours.
Pizzi S; D'Adda T; Azzoni C; Rindi G; Grigolato P; Pasquali C; Corleto VD; Delle Fave G; Bordi C
J Pathol; 2002 Apr; 196(4):401-7. PubMed ID: 11920735
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity and microsatellite instability as predictive markers for neoadjuvant treatment in gastric carcinoma.
Grundei T; Vogelsang H; Ott K; Mueller J; Scholz M; Becker K; Fink U; Siewert JR; Höfler H; Keller G
Clin Cancer Res; 2000 Dec; 6(12):4782-8. PubMed ID: 11156235
[TBL] [Abstract][Full Text] [Related]
6. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma.
Yatsuoka T; Sunamura M; Furukawa T; Fukushige S; Yokoyama T; Inoue H; Shibuya K; Takeda K; Matsuno S; Horii A
Am J Gastroenterol; 2000 Aug; 95(8):2080-5. PubMed ID: 10950061
[TBL] [Abstract][Full Text] [Related]
7. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.
Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Koutroumbi E; Markopoulos C; Gogas J; Kittas C
Anticancer Res; 2001; 21(2A):991-9. PubMed ID: 11396193
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity in pancreatic endocrine tumors.
Tang SJ; Dumot JA; Wang L; Memmesheimer C; Conwell DL; Zuccaro G; Goormastic M; Ormsby AH; Cowell J
Am J Gastroenterol; 2002 Apr; 97(4):1022-30. PubMed ID: 12003383
[TBL] [Abstract][Full Text] [Related]
9. Fractional allelic loss in gastric carcinoma correlates with growth patterns.
Choi SW; Park SW; Lee KY; Kim KM; Chung YJ; Rhyu MG
Oncogene; 1998 Nov; 17(20):2655-9. PubMed ID: 9840929
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
[TBL] [Abstract][Full Text] [Related]
11. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic and molecular analyses of multiple endocrine neoplasias of the MEN1 syndrome.
Pourani J; Kaserer K; Pfragner R
Int J Oncol; 2002 May; 20(5):971-6. PubMed ID: 11956591
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
14. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity of chromosome 1q in gastrinomas: occurrence and prognostic significance.
Chen YJ; Vortmeyer A; Zhuang Z; Huang S; Jensen RT
Cancer Res; 2003 Feb; 63(4):817-23. PubMed ID: 12591732
[TBL] [Abstract][Full Text] [Related]
16. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma.
Ott K; Vogelsang H; Mueller J; Becker K; Müller M; Fink U; Siewert JR; Höfler H; Keller G
Clin Cancer Res; 2003 Jun; 9(6):2307-15. PubMed ID: 12796400
[TBL] [Abstract][Full Text] [Related]
18. Deletion of chromosome 1 predicts prognosis in pancreatic endocrine tumors.
Ebrahimi SA; Wang EH; Wu A; Schreck RR; Passaro E; Sawicki MP
Cancer Res; 1999 Jan; 59(2):311-5. PubMed ID: 9927038
[TBL] [Abstract][Full Text] [Related]
19. Frequent deletion of chromosome 3 in malignant sporadic pancreatic endocrine tumors.
Guo SS; Arora C; Shimoide AT; Sawicki MP
Mol Cell Endocrinol; 2002 Apr; 190(1-2):109-14. PubMed ID: 11997184
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite DNA alterations of gastrointestinal stromal tumors are predictive for outcome.
Schurr P; Wolter S; Kaifi J; Reichelt U; Kleinhans H; Wachowiak R; Yekebas E; Strate T; Kalinin V; Simon R; Sauter G; Schaefer H; Izbicki J
Clin Cancer Res; 2006 Sep; 12(17):5151-7. PubMed ID: 16951233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
